Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers.
about
Integrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 1Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular DisordersEffects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteersDrug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Interactions between herbs and conventional drugs: overview of the clinical data.Evaluation of metabolism-mediated herb-drug interactions.Inhibition of human cytochromes P450 by components of Ginkgo biloba.In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesCytochrome P450 enzyme mediated herbal drug interactions (Part 1)Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo bilobaAssessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers.Herb-drug interactions: an overview of the clinical evidence.Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer.Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.Identification of Ginkgo biloba as a novel activator of pregnane X receptor.Clinically based evidence of drug-herb interactions: a systematic review.Herb-drug pharmacokinetic interactions reviewed.Herb-drug interactions: focus on metabolic enzymes and transporters.Induction of cytochrome P450 enzymes: a view on human in vivo findings.Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.Pharmacokinetic drug interactions involving Ginkgo biloba.Which medications used in paediatric practice have demonstrated natural health product-drug interactions?: Part A: Evidence-based answer and summary.Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and Ginkgo biloba extracts in healthy subjects.Influence of the Ginkgo extract EGb 761 on rat liver cytochrome P450 and steroid metabolism and excretion in rats and man.Effect of Ginkgo biloba extract on plasma steroid concentrations in healthy volunteers: a pilot study.Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.Effects ofGinkgo bilobaextracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices
P2860
Q26771931-98EF4ABC-56B9-4DE0-BEC8-9BA023F0B61BQ27006921-98507AD5-C774-4891-8307-EC3760BB3BECQ28750369-80743F79-8074-4983-8478-0D46C03E88E1Q33509452-533F78D5-7B08-4548-91B1-38C8789AED36Q34124444-36403F37-0E5B-4661-9568-AEFAADAAFD40Q34238039-848DECBC-D747-4041-9B0C-F25D5DE37235Q34337497-56EEE5D8-CB19-49C8-A4B9-251B15BDB6ADQ34419646-D6E7B4F3-5B16-4F78-AECD-4AE90516E5D4Q35725540-ECC4B0A4-B29F-492E-AB03-3507BBBD9758Q35765836-FFE873DD-DC5C-463B-8F0A-E40B954C725CQ35781985-8E62B149-186B-4421-BEBE-F4A7393BED2FQ35904433-7333A965-B543-4C0F-B1DE-A3E187B88C41Q36014951-A12F6E38-EE30-4F1C-9B1F-A1EA2B8EB9D9Q36762928-9FC6E36F-BD9D-49F1-9B7C-7D90C9ACF97EQ36926307-1C105CFA-67CA-46A6-B9FE-F438AD219114Q37061726-E1329C24-3106-430C-BBF3-82079D0D37D2Q37658866-D48B3933-9F05-4998-9B29-9A24132F2322Q37808478-629DE3D6-A14C-44A7-8A26-E726038A7775Q37964576-76B80078-CCEE-48D6-BBD3-F88D20A32850Q38057372-4E0F3440-3347-4705-A2B2-FB38DED78F18Q38109094-6F8D88AE-83FE-4282-9A07-11DFFBFC5D05Q38122439-DA81F16D-0E26-464A-8FA5-177D6E3B7874Q42140204-BE624F65-0463-49F0-9288-C6AE70A78452Q44081116-7C0F388B-9BB6-4DCF-8BB8-2F74319D1A82Q46496826-EECC9381-3487-4578-BBB5-2FB7BEDB09F8Q46721369-C8EA0974-BF1A-40FB-AD1B-B6DE5D9BBE5CQ48651682-138EAF86-D31D-4078-83CE-1CBF0BB65F19Q50077257-3B2A76DE-A179-4FC0-BCA6-F4D5E5D23CB1Q57500258-F896E711-DC9A-4649-96BB-F9AAA4AFE24B
P2860
Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Multiple-dose administration o ...... activity in normal volunteers.
@ast
Multiple-dose administration o ...... activity in normal volunteers.
@en
Multiple-dose administration o ...... activity in normal volunteers.
@nl
type
label
Multiple-dose administration o ...... activity in normal volunteers.
@ast
Multiple-dose administration o ...... activity in normal volunteers.
@en
Multiple-dose administration o ...... activity in normal volunteers.
@nl
prefLabel
Multiple-dose administration o ...... activity in normal volunteers.
@ast
Multiple-dose administration o ...... activity in normal volunteers.
@en
Multiple-dose administration o ...... activity in normal volunteers.
@nl
P2093
P1476
Multiple-dose administration o ...... activity in normal volunteers.
@en
P2093
C Lindsay DeVane
Jennifer L Donovan
John S Markowitz
Kenneth D Chavin
Laura Sipkes
P304
P356
10.1097/01.JCP.0000095340.32154.C6
P407
P577
2003-12-01T00:00:00Z